DalsnaFinance Account

Becton Dickinson $BDX

Health Care · Health Care Equipment · NYSE/NASDAQ

S&P 500 Russell 1000 New Jersey

Create a scorecard

$193.80

+3.06 (+1.60%)

As of Oct 20, 2026, 6:42 PM EDT · cached

Price history

Loading chart…

Key facts

52-week range (closes): $138.67 – $192.00 Lowest close Nov 5, 2025, highest Aug 21, 2026; 251 daily closes to Oct 13, 2026 from Dalsna Finance's price archive
Fiscal year ends: September Fiscal 2025 ended Sep 30, 2025, from SEC filings
In the S&P 500 since: Sep 30, 1972 · All S&P 500 changes

Becton Dickinson (BDX) is trading up at $193.80 (+1.60%) on NYSE/NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Health Care sector.

Becton Dickinson revenue & net income history (FY2016–FY2025)

RevenueNet incomeNet margin (right axis, %)

Becton Dickinson annual financial statements
	FY2016Sep 2016	FY2017Sep 2017	FY2018Sep 2018	FY2019Sep 2019	FY2020Sep 2020	FY2021Sep 2021	FY2022Sep 2022	FY2023Sep 2023	FY2024Sep 2024	FY2025Sep 2025
Income statement
Revenue	$12.5B	$12.1B	$16.0B	$17.3B	$16.1B	$19.1B	$18.9B	$19.4B	$20.2B	$21.8B
Growth (year over year)	+21.4%	−3.1%	+32.2%	+8.2%	−7.0%	+19.0%	−1.4%	+2.7%	+4.2%	+8.2%
Gross profit	$5.99B	$5.94B	$7.27B	$8.29B	$7.58B	$8.63B	$8.48B	$8.17B	$9.13B	$9.93B
Gross margin	48.0%	49.1%	45.5%	47.9%	47.1%	45.1%	44.9%	42.2%	45.2%	45.4%
Operating income	$1.43B	$1.52B	$1.51B	$1.76B	$912.0M	$2.25B	$2.28B	$2.11B	$2.40B	$2.58B
Operating margin	11.5%	12.6%	9.4%	10.2%	5.7%	11.8%	12.1%	10.9%	11.9%	11.8%
Net income	$976.0M	$1.10B	$311.0M	$1.23B	$874.0M	$2.09B	$1.78B	$1.48B	$1.71B	$1.68B
Net margin	7.8%	9.1%	1.9%	7.1%	5.4%	10.9%	9.4%	7.7%	8.4%	7.7%
EPS (diluted)	$4.49	$4.60	$0.60	$3.94	$2.71	$6.85	$5.88	$4.94	$5.86	$5.82
Balance sheet
Cash and equivalents	$1.54B	$14.2B	$1.14B	$536.0M	$2.83B	$2.28B	$1.01B	$1.42B	$1.72B	$567.0M
Total assets	$25.6B	$37.7B	$53.9B	$51.8B	$54.0B	$53.9B	$52.9B	$52.8B	$57.3B	$55.3B
Total liabilities	$18.0B	$24.8B	$32.9B	$30.7B	$30.2B	$30.2B	$27.7B	$27.0B	$31.4B	$29.9B
Long-term debt	$10.6B	$18.7B	$18.9B	$18.1B	$17.2B	$17.1B	$13.9B	$14.7B	$17.9B	$17.6B
Shareholders' equity	$7.63B	$12.9B	$21.0B	$21.1B	$23.8B	$23.7B	$25.3B	$25.8B	$25.9B	$25.4B
Cash flow
Operating cash flow	$2.56B	$2.55B	$2.87B	$3.33B	$3.54B	$4.65B	$2.47B	$2.99B	$3.84B	$3.43B
Capital expenditure	$693.0M	$727.0M	$895.0M	$957.0M	$769.0M	$1.19B	$973.0M	$874.0M	$725.0M	$760.0M
Free cash flow	$1.87B	$1.82B	$1.97B	$2.37B	$2.77B	$3.45B	$1.50B	$2.12B	$3.12B	$2.67B
Dividends paid	$562.0M	$677.0M	$927.0M	$984.0M	$1.03B	$1.05B	$1.08B	$1.11B	$1.10B	$1.20B
Share buybacks	$0	$220.0M	$0	$0	$0	$1.75B	$500.0M	$0	$500.0M	$1.00B

RevenueNet incomeNet margin (right axis, %)

Becton Dickinson quarterly financial statements
	Q4 FY24^†Sep 2024	Q1 FY25Dec 2024	Q2 FY25Mar 2025	Q3 FY25Jun 2025	Q4 FY25^†Sep 2025	Q1 FY26Dec 2025	Q2 FY26Mar 2026	Q3 FY26Jun 2026
Income statement
Revenue	$5.44B	$5.17B	$4.48B	$4.73B	$7.47B	$5.25B	$4.71B	$4.98B
Growth (year over year)	+6.9%	+9.8%	−11.2%	−5.3%	+37.3%	+1.6%	+5.2%	+5.4%
Gross profit	$2.49B	$2.23B	$1.86B	$2.23B	$3.59B	$2.41B	$2.15B	$2.31B
Gross margin	45.7%	43.2%	41.5%	47.3%	48.1%	45.9%	45.7%	46.5%
Operating income	$622.0M	$453.0M	$383.0M	$739.0M	$1.00B	$552.0M	$93.0M	$663.0M
Operating margin	11.4%	8.8%	8.5%	15.6%	13.4%	10.5%	2.0%	13.3%
Net income	$400.0M	$303.0M	$308.0M	$574.0M	$493.0M	$382.0M	−$311.0M	$377.0M
Net margin	7.4%	5.9%	6.9%	12.1%	6.6%	7.3%	−6.6%	7.6%
EPS (diluted)	$1.37	$1.04	$1.07	$2.00	$1.71	$1.34	−$1.11	$1.37
Balance sheet
Cash and equivalents	$1.72B	$711.0M	$667.0M	$735.0M	$567.0M	$740.0M	$813.0M	$708.0M
Total assets	$57.3B	$54.7B	$54.5B	$54.9B	$55.3B	$54.8B	$50.8B	$50.7B
Total liabilities	$31.4B	$29.5B	$29.2B	$29.4B	$29.9B	$29.6B	$26.7B	$26.3B
Long-term debt	$17.9B	$17.4B	$17.7B	$17.5B	$17.6B	$16.9B	$14.7B	$13.5B
Shareholders' equity	$25.9B	$25.2B	$25.2B	$25.5B	$25.4B	$25.3B	$24.1B	$24.4B
Cash flow
Operating cash flow	$1.18B	$693.0M	−$204.0M	$1.09B	$1.85B	$657.0M	$671.0M	$776.0M
Capital expenditure	$296.0M	$105.0M	$114.0M	$164.0M	$377.0M	$108.0M	$125.0M	$143.0M
Free cash flow	$882.0M	$588.0M	−$318.0M	$925.0M	$1.48B	$549.0M	$546.0M	$633.0M
Dividends paid	$275.0M	$302.0M	$298.0M	$299.0M	$297.0M	$299.0M	$290.0M	$286.0M
Share buybacks	$0	$750.0M	$0	$0	$250.0M	$250.0M	$2.00B	$0

From Becton Dickinson's 10-K and 10-Q filings with the SEC; its fiscal year ends in September. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →

Becton Dickinson vs the Health Care sector and the S&P 500

Becton Dickinson's latest reported figures next to the median of the other 59 S&P 500 Health Care companies and of the other 502 S&P 500 companies; each median is taken over the companies with a comparable figure (counts in the footnote). A median is the middle value, not an average, so one very large company does not move it.

Becton Dickinson compared with the median Health Care company and the median S&P 500 company
Measure	Becton Dickinson	Health Care (59 other S&P 500 companies)	S&P 500 (502 other companies)
Revenue growth, latest fiscal year	+8.2%	+7.1%	+7.0%
Net margin, latest fiscal year	7.7%	13.1%	13.0%
Dividend per share, latest fiscal year	$4.16	$2.43	$2.40
Share price change, 1 year	+29.1%	+22.0%	+7.5%

Becton Dickinson: fiscal year ended September 2025, from its 10-K and 10-Q filings with the SEC. Medians computed October 20, 2026 from each company's latest annual filing (fiscal years ending between July 2025 and September 2026) and our price archive. Prices for every company, Becton Dickinson included, are the last regular-session prices of October 20, 2026; the 1-year change compares that price with each company's last close on or before October 20, 2025. Net margin and price change are our calculations from reported figures. Each median counts only the companies with a comparable figure (sector / S&P 500): revenue growth 59/496, net margin 59/496, dividend per share 32/349, 1-year price change 59/488; the reasons below can overlap. 14 are left out of the price figure because our archive holds no comparable close for them; dividend medians are among the 32 sector and 349 S&P 500 companies reporting a per-share dividend. The S&P 500 price figure is the middle company's change, not the index's return.

About Becton Dickinson

Becton, Dickinson and Company is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain areas.

Source: Wikipedia — BD (company)